+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors



Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors



Psychogeriatrics 18(5): 365-370



Depression is one of the most prevalent causes of distress in the geriatric population. The purpose of this study was to examine the prevalence of depressive symptoms in elderly cancer patients and to determine the possible associated factors. Cancer patients 65 years or older and on active chemotherapy completed the Yesavage Geriatric Depression Scale. We examined the relationship of depressive symptoms with age, gender, marital status, educational background, type of cancer, stage of disease, comorbidities, types of treatment for cancer, the duration after diagnosis of cancer, social support, and pain status. The study included 170 patients with a mean age of 71 years, and 47.1% were women. The prevalence of a high depressive symptom score was 19.4%. Of the patients who had a high depressive symptom score based on the Yesavage Geriatric Depression Scale, 18.2% had already been diagnosed with depression and used antidepressants. The mean pain score was significantly higher in patients who had a high depressive symptom score compared to others (P = 0.012). The prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy was similar to that in the geriatric population without cancer. It was also consistent with previous studies on elderly cancer population. Pain was found to be a factor related to depressive symptoms. The prevalence of depression may be reduced by pain control. The treatment of depression may both improve the patient's quality of life and enhance their compliance with treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 065431519

Download citation: RISBibTeXText

PMID: 29998465

DOI: 10.1111/psyg.12329


Related references

Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy. Psycho-Oncology 26(1): 15-21, 2016

Factors associated with depressive symptoms in cancer family caregivers of patients receiving chemotherapy. Supportive Care in Cancer 21(9): 2387-2394, 2014

Prevalence and related influencing factors of depressive symptoms among empty-nest elderly in Shanxi, China. Journal of Affective Disorders 245: 750-756, 2018

Prevalence and related influencing factors of depressive symptoms for empty-nest elderly living in the rural area of YongZhou, China. Archives of Gerontology and Geriatrics 50(1): 24-29, 2010

Prevalence of depressive symptoms and related risk factors for depressive symptoms among elderly persons living in a rural Japanese community: a cross-sectional study. Community Mental Health Journal 43(6): 583-590, 2007

Prevalence of depressive symptoms and associated factors in elderly primary care patients: a descriptive study. Primary Care Companion to the Journal of Clinical Psychiatry 10(6): 462-468, 2008

Depressive symptoms in elderly patients after a somatic illness event: prevalence, persistence, and risk factors. Psychosomatics 47(1): 33-42, 2005

Mild cognitive impairment and depressive symptoms in elderly patients with diabetes: prevalence, risk factors, and comorbidity. Journal of Diabetes Research 2014: 179648, 2015

Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting. Current Oncology Reports 20(5): 38, 2018

Trajectory and influencing factors of depressive symptoms in family caregivers before and after the death of terminally ill patients with cancer. Oncology Nursing Forum 40(1): E32-E40, 2013

Depressive symptoms during adverse economic and political circumstances: A comparative study on Greek female breast cancer patients receiving chemotherapy treatment. European Journal of Cancer Care 26(6), 2017

Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy. Supportive Care in Cancer 20(8): 1885-1893, 2012

Depressive symptoms in the elderly. Prevalence and associated factors. Gaceta Sanitaria 21(1): 37-42, 2007

Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Medical Weekly 141: W13303, 2012

Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology 19(9): 2381-2389, 2001